CA Lotus Investments, an investment arm of the Carlyle Group, sold its shareholding in Metropolis Healthcare on the stock market via a block trade. The block trade marks Carlyle’s near-exit from Metropolis.
Prior to the trade, Carlyle held a 14.31% stake of the equity share capital, which was reduced to 1.25%. The promoters of Metropolis were given a call option on a portion of the equity shares held by Carlyle.
L&L Partners was domestic legal counsel to CA Lotus Investments. “The firm was also involved in drafting, negotiating and finalizing the transaction documents with several banks, of which Carlyle finally entered into final transaction documentation with Goldman Sachs and Citibank,” said Bikash Jhawar, a partner at L&L Partners.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
